These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5127493)

  • 1. Subacute myelo-optic neuropathy and the halogenated hydroxyquinolines.
    Med J Aust; 1971 Nov; 2(21):1090-1. PubMed ID: 5127493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abdominal symptoms of subacute myelo-optico-neuropathy (SMON)--with special reference to relationship between chinoform and ileus-like symptoms].
    Inoue N; Tamura K; Kuroiwa Y; Ysukochi T; Naritomi T
    Rinsho Shinkeigaku; 1973 Sep; 13(9):537-42. PubMed ID: 4796521
    [No Abstract]   [Full Text] [Related]  

  • 3. The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
    Oakley GP
    JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059
    [No Abstract]   [Full Text] [Related]  

  • 4. [SMON (subacute myelo-optico-neuropathy)].
    Kaeser HE
    Schweiz Rundsch Med Prax; 1972 Jul; 61(29):927-30. PubMed ID: 4655587
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aetiological and clinical study on subacute myelo-optico-neuropathy (SMON) (author's transl)].
    Tsubaki T
    Nihon Naika Gakkai Zasshi; 1974 Jan; 63(1):1-17. PubMed ID: 4856733
    [No Abstract]   [Full Text] [Related]  

  • 6. [Extensive leucoencephalopathy combined with subacute myelo-optico-neuropathy].
    Tateishi J; Hayabara T; Kuroda S; Kadota K; Hayashi Y
    Rinsho Shinkeigaku; 1974 Mar; 14(3):286-92. PubMed ID: 4472738
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ocular disorders in SMON (subacute myelo-optico neuropathy), especially neuro-retinal lesions].
    Okuda K; Matsuo H; Ueno H
    Nippon Ganka Gakkai Zasshi; 1971; 75(8):1937-43. PubMed ID: 5165911
    [No Abstract]   [Full Text] [Related]  

  • 8. Subacute myelo-optico-neuropathy (S.M.O.N.) in Japan. A community survey.
    Nakae K; Yamamoto S; Igata A
    Lancet; 1971 Sep; 2(7723):510-2. PubMed ID: 4105662
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subacute myelo-optico neuropathy (SMON) in Hokkaido, an epidemiological study (report II). Considering age and sex as factors in SMON (author's transl)].
    Kasai M
    Nihon Eiseigaku Zasshi; 1974 Jun; 29(2):312-20. PubMed ID: 4475236
    [No Abstract]   [Full Text] [Related]  

  • 10. [SMON-- Japanese disease?].
    Dölle W
    Internist (Berl); 1971 Sep; 12(9):405-6. PubMed ID: 4938935
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subacute myelo-optico-neuropathy (SMON) in Japan. The question of chinoform poisoning].
    Igata A; Toyokura Y
    Munch Med Wochenschr; 1971 Jul; 113(31):1062-6. PubMed ID: 5109393
    [No Abstract]   [Full Text] [Related]  

  • 12. [Subacute myelo-optic neuropathy--toxic reaction or viral disease?].
    Dimov D
    Lijec Vjesn; 1972 Jul; 94(7):363-6. PubMed ID: 4266549
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropathology of subacute myelo-optico-neuropathy, "SMON".
    Shiraki H
    Jpn J Med Sci Biol; 1971 Aug; 24(4):217-43. PubMed ID: 5316312
    [No Abstract]   [Full Text] [Related]  

  • 14. Subacute myelo-optico-neuropathy (SMON).
    Nelson E
    Ann Intern Med; 1972 Sep; 77(3):468-70. PubMed ID: 4262315
    [No Abstract]   [Full Text] [Related]  

  • 15. [SMON and chinoform].
    Tamura Z
    Tanpakushitsu Kakusan Koso; 1973 Mar; 18(3):210-4. PubMed ID: 4197094
    [No Abstract]   [Full Text] [Related]  

  • 16. [Subacute myelo-optico neuropathy (author's transl)].
    Heilig P; Thaler A
    Klin Monbl Augenheilkd; 1974 Mar; 164(3):386-8. PubMed ID: 4277280
    [No Abstract]   [Full Text] [Related]  

  • 17. Subacute myelo-optic neuropathy in Australia.
    Selby G
    Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3].
    Aoyama H; Oira M; Ota T; Yoshioka S; Yoshida T
    Nihon Eiseigaku Zasshi; 1970 Dec; 25(5):468-71. PubMed ID: 4251106
    [No Abstract]   [Full Text] [Related]  

  • 19. [SMON and chinoform: search for the causative agent].
    Tsubaki T; Honma Y; Hoshi M
    Naika; 1971; 28(3):451-5. PubMed ID: 5097705
    [No Abstract]   [Full Text] [Related]  

  • 20. [Subacute myelo-optico-neuropathy following use of large amounts of iodochlorhydroxyquinoline (Enterovioform)].
    Bron HL; Korten JJ; Pinckers AJ; Majoor CL
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1615-8. PubMed ID: 4262825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.